Dr. Jessica Gordon is an Associate Attending Physician in the Division of Rheumatology at Hospital for Special Surgery and an Associate Professor of Clinical Medicine at Weill Cornell Medicine. She specializes in the treatment of patients with systemic sclerosis (scleroderma), and her research focus is developing improved therapies for patients with this condition. She also specializes in the care patients with Raynaud phenomenon, mixed connective tissue disease, interstitial lung disease associated with connective tissue disease, Sjogren’s syndrome, systemic lupus erythematosus, rheumatoid arthritis, and other conditions. She is the HSS Scleroderma clinic chief. She has been recognized for several years as a "Top Doctor" by Castle/Connolly and New York magazine.
Dr. Gordon completed her undergraduate studies at Brown University in 1993. She received her MD degree from State University of New York at Stony Brook where she graduated Alpha Omega Alpha. She completed her internal medicine residency and chief residency at Georgetown University Hospital in Washington, DC. She then went on to complete her fellowship in Rheumatology at Hospital for Special Surgery. Following this she joined the faculty at HSS in 2010 where she continues to practice Rheumatology.
Dr. Gordon conducts clinical and translational research in systemic sclerosis. She is an investigator in multiple clinical trials and observational studies with this focus. She has been the recipient of numerous grants and awards including the Kellen Family Clinical Scientist Development Award, the Scleroderma Foundation New Investigator Grant, the Charles L. Christian Award for Excellence in Musculoskeletal Research, and the American College of Rheumatology Distinguished Fellow Award.
Associated interstitial lung disease
Connective tissue disease
Mixed connective tissue disease
Systemic lupus erythematosus
Intra-articular and intra-bursal aspirations and injections
Please call our office if you have questions regarding your insurance coverage. If you have out of network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Associate Attending Physician, Hospital for Special Surgery
Associate Professor of Medicine, Weill Cornell Medical College
Member, American College of Rheumatology
Member, American Medical Association
Scleroderma Foundation Medical Advisory Board
Internal Medicine, 2005
Castle Connolly Top Doctors in New York Metro Area, 2017-2022
Castle Connolly Regional Top Doctor, 2017-2021
New York Magazine Top Doctors, 2017-2022
Exceptional Women In Medicine: 2019, 2020
Charles L. Christian Award for Excellence in Musculoskeletal Research, 2010
Department of Medicine Fellow Award - Finalist, 2010
American College of Rheumatology Distinguished Fellow Award, 2009
Certificate of Appreciation – Scleroderma Foundation – Tristate Chapter, 2009
Donald Knowlan Award, Georgetown University Hospital, Dept. of Internal Medicine, 2005
Janet Glasgow Memorial Achievement Citation, American Medical Women’s Society, 2002
Alpha Omega Alpha Honor Society, 2001
MD, State University of New York at Stony Brook, Stony Brook, NY 2002
MS, Clinical Investigation, Cornell University, NY 2010
Internal Medicine, Georgetown University Hospital, Washington, DC
Internal Medicine, Georgetown University Hospital, Washington, DC
Rheumatology, Hospital for Special Surgery
English, Spoken by Office Staff: Spanish
Gordon JK, Martyanov V, Franks JM, Bernstein EJ, Szymonifka J, Magro C, Wildman HF, Wood TA, Whitfield ML, Spiera RF. Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial. Arthritis Rheumatol. 2017 Oct 26. doi: 10.1002/art.40358. PMID: 29073351.
Showalter K, Spiera R, Magro C, Agius P, Martyanov V, Franks JM, Sharma R, Geiger H, Wood TA, Zhang Y, Hale CR, Finik J, Whitfield ML, Orange DE, Gordon JK. Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvement. Ann Rheum Dis. 2021 Feb;80(2):228-237. doi: 10.1136/annrheumdis-2020-217840. Epub 2020 Oct 7. PubMed PMID: 33028580.
Gordon JK, Martyanov V, Magro CM, Wildman HF, Wood TA, Huang WT, Crow MK, Whitfield ML, Spiera RF. Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial. Arthritis Research & Therapy. 2015; 17(1):213
Gordon JK, Udeh U, Doobay K, Magro C, Wildman HF, Davids M, Mersten JN, Huang WT, Lyman S, Crow MK, Spiera RF. Imatinib Mesylate (Gleevec™) in the Treatment of Diffuse Cutaneous Systemic Sclerosis: Results of a 24 Month Open Label, Extension Phase, Single Center Trial, Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-189-93. Epub 2014 Aug 15.
Spiera RF, Gordon JK, Mersten JN, Magro CM, Mehta M, Wildman HF, Kloiber S, Kirou KA, Lyman S, Crow MK. Imatinib Mesylate (Gleevec™) in the Treatment of Diffuse Cutaneous Systemic Sclerosis: Results of a One Year, Phase IIa, Single Arm, Open Label Clinical Trial. Ann Rheum Dis. 2011 Jun;70(6):1003-9. Epub 2011 Mar 11.
Chia JJ, Zhu T, Chyou S, Dasoveanu DC, Carballo C, Tian S, Magro CM, Rodeo S, Spiera RF, Ruddle NH, McGraw TE, Browning JL, Lafyatis R, Gordon JK, Lu TT. Dendritic cells maintain dermal adipose-derived stromal cells in skin fibrosis. J Clin Invest. 2016 Nov 1;126(11):4331-4345.
Lofgren S, Hinchcliff M, Carns M, Wood T, Aren K, Arroyo E, Cheung P, Kuo A, Valenzuela A, Haemel A, Wolters PJ, Gordon J, Spiera R, Assassi S, Boin F, Chung L, Fiorentino D, Utz PJ, Whitfield ML, Khatri P. Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity. JCI Insight. 2016 Dec 22;1(21):e89073.
Ah Kioon MD, Tripodo C, Fernandez D, Kirou KA, Spiera RF, Crow MK, Gordon JK, Barrat FJ. Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8. Sci Transl Med. 2018 Jan 10;10(423):eaam8458. doi: 10.1126/scitranslmed.aam8458. PMID: 29321259.
Rice LM, Mantero JC, Stifano G, Ziemek J, Simms RW, Gordon J, Domsic R, Lafyatis R. A Proteome-Derived Longitudinal Pharmacodynamic Biomarker for Diffuse Systemic Sclerosis Skin. J Invest Dermatol. 2017 Jan;137(1):62-70.
Chung L, Domsic RT, Lingala B, Alkassab F, Bolster M, Csuka ME, Derk C, Fischer A, Frech T, Furst DE, Gomberg-Maitland M, Hinchcliff M, Hsu V, Hummers LK, Khanna D, Medsger TA Jr, Molitor JA, Preston IR, Schiopu E, Shapiro L, Silver R, Simms R, Varga J, Gordon JK, Steen VD. Survival and predictors of mortality in systemic sclerosis associated pulmonary arterial hypertension: Outcomes from the PHAROS registry. Arthritis Care Res (Hoboken). 2013 Aug 27. doi: 10.1002/acr.22121.
For more publications, please see the PubMed listing.
One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
Below are the healthcare industry relationships reported by Dr. Gordon as of December 16, 2019.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
Patients should feel free to ask their HSS physicians questions about these relationships.